ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

Eight Win ASCO Young Investigator Awards

August 22, 1986

Environmental Carcinogenesis Seen As Next Big Growth Field; NCA Hears Problems, Priorities

October 31, 1975

DCBD To Increase Emphasis On Workshops, Cut Program Initiatives

November 8, 1985

Komen, Baylr, UT Southwestern Form Alliance

November 13, 1987

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002